JGCM
DXCM icon

Joseph Group Capital Management’s DexCom DXCM Stock Holding History

Joseph Group Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.75K Buy
+115
New +$7.66K ﹤0.01% 357

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Joseph Group Capital Management's DXCM Position: Q2 2026 in Review

Joseph Group Capital Management opened a new position in DexCom (DXCM) in Q2 2026: 115 shares worth $7.75K. The stake represents ﹤0.01% of the portfolio and ranks #357 among its holdings.

968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Joseph Group Capital Management held 115 shares of DexCom worth $7.75K as of Q2 2026.
  • DexCom was a new Joseph Group Capital Management position in Q2 2026.
  • DexCom made up ﹤0.01% of Joseph Group Capital Management's portfolio in Q2 2026, its #357 holding.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.